Additional Reading
- Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis. – Siedhoff, MT et al. – Am J Obstet Gynecol. 2015 May;212(5):591.e1
- An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. – Parker, W et al. – J Minim Invasive Gynecol. 2016 Mar-Apr; 23(3):303-308
- Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation. – Harris, J et al. – Am J Obstet Gynecol. 2016 Jan; 214(1):98.e1-98.e13
- Outcome of Occult Uterine Leiomyosarcoma After Surgery for Presumed Fibroids: A Systematic Review. – Pritts, et al. – 2015 Jan. J Minim Invasive Gynecol. 22(1):26–33
- The Unintended Consequences of an FDA Warning: The Case of Power Morcellation in Myoma Surgery. – Po, L and Lee, PE – J Minim Invasive Gynecol. 2016;23:597-602
- Choosing the Route of Hysterectomy for Benign Disease – Matteson, KA et al- American College of Obstetrics and Gynecologists. June 2017
- Content Type
